SHELTON, CONNECTICUT / ACCESS Newswire / October 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), announced that Nanoviricides CEO Dr Anil Diwan joined ...

Buffalo has undergone an incredible transformation over the past 15 years regarding high-growth tech. The venture studio’s goal is to take these positive signals and turn them into durable growth by ...

Return to shareholders -- $1.4 billion was returned to shareholders as of fiscal Q3 2025 through dividends and share repurchases. Anticipated step-up in expenses -- Research and development, as well ...

Bausch Health Companies delivered strong Q3 results, with revenue up 6.8% year-over-year and EPS beating estimates by $0.10.

SDLC guides teams to plan, build, test, and deliver software. Discover phases, KPIs, tools, and checklist with our quick ...

Q3 2025 Earnings Call October 30, 2025 10:00 AM EDTCompany ParticipantsHeli Jamsa - IR ManagerJuha Varelius - President ...

FDA issues new guidance aimed at speeding biosimilar time to market and lower costs, and more in the latest National Advocacy ...

Experts tell Newsweek how automakers are reducing development timelines to stay competitive with Chinese companies.

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex ...

The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.The agency issued draft guidance that would simplify the study ...

Attendees must register online for free to enjoy the festivities that include self-guided tours, a car show, live ...

Incremental product launches and business divestures will define the next few years at the Minnesota-based manufacturer.